Patented non-cavitational acoustic technology that enables direct crystallisation of cocoa butter into Form V from the melt, eliminating traditional tempering. Validated at pilot scale on anhydrous milk fat and waxes, offering chocolate manufacturers a clean-label, additive-free approach to polymorph control.
This patented acoustic technology uses low-power, non-cavitational ultrasound to control crystal nucleation and polymorph selection in lipid systems. The approach enables cocoa butter and chocolate manufacturers to achieve the desirable Form V polymorph directly from the melt, without the need for conventional tempering, seeding agents, or chemical additives. The same underlying intellectual property has already been demonstrated to separate stearin and olein fractions in anhydrous milk fat without chemical modification, indicating broad applicability across edible fats and related crystallisation processes.
For chocolate producers, confectioners, and ingredient suppliers, the technology offers a route to cleaner labels, simplified processing, and improved product consistency, while preserving the organoleptic qualities of the fat. It is supported by an issued patent and peer-reviewed experimental and theoretical validation.
Key features:
The technology has reached pilot plant scale proof of principle in related lipid systems, including anhydrous milk fat and waxes, as documented in peer-reviewed work. An industrial-scale prototype has been constructed and is available for further validation. The next stage involves demonstrating direct Form V crystallisation of cocoa butter from the melt using the existing pilot equipment, which represents the critical step toward commercial deployment in chocolate and confectionery manufacturing.
The University of Leeds is a comprehensive, research‑intensive public university serving a large student body and global partner network. Industry partners engage through an on‑campus innovation hub offering flexible workspace, shared labs and prototyping, and options to co‑locate with academic experts. The university’s integration with major NHS teaching hospitals in the city enables clinical research, validation, and translation. Research is backed by competitive funding from UK Research and Innovation (UKRI) councils and the National Institute for Health and Care Research, with additional European and industry support. A dedicated technology transfer office manages IP, licensing, and spinouts, with partnership models and professional education tailored for corporate R&D.